EpiFinder, Inc., is pleased to announce its proprietary clinical decision analytics software to improve epilepsy syndrome diagnosis and seizure event management at the point-of-care. The early-stage Arizona company provides intelligent analytics and support to doctors, neurologists and healthcare professionals (Nurse Practitioners, Physician Assistants, and more) to enhance the lives of patients with epilepsy.
The US health regulator has denied approval to Sun Pharma Advanced Research Company’s (SPARC) new drug application for Elepsia XR, an anti-epileptic drug. The company has received a Complete Response Letter (CRL) from the USFDA for its new drug application for Elepsia XR, Levetiracetam extended-release tablets in strengths of 1,000 mg and 1,500 mg, SPARC […]
A University of Warwick study to understand a form of epilepsy that affects children has received a grant from the charity Epilepsy Research UK. The research focuses on absence epilepsy which is largely a childhood condition which is characterized by sudden, brief interruptions of consciousness. In severe cases there may be more than 200 of […]
Elizabeth Szasz is 12 years old but is unable to lead the typical life of a middle schooler. She was diagnosed with epilepsy as a baby and has tried several treatments for her life-threatening seizures. Each new treatment would work for a short time. But her seizures, which can last longer than two hours would […]
A protein that may help epilepsy patients respond better to drug therapies has been identified, a new study suggests. The study, titled “Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy,” was published in the The Journal of Clinical Investigation.
A little Whanganui girl whose classmates refused to come to her birthday is about to be flooded with friends, presents and birthday well-wishes from all over the world. Gabi Barnett, 9, has suffered some setbacks in the last two years. Merciless bullying by another girl has made Gabi shy and withdrawn. Her mum Toni says […]